Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Biotech
'Not a cost-cutting exercise': Novo Nordisk reshapes R&D setup
Novo Nordisk may be reorganizing its early-stage R&D teams, but the Danish pharma’s CSO insisted the changes aren’t primarily about laying off staff.
James Waldron
Mar 20, 2025 10:15am
Opko, Entera share cost of 1st oral GLP-1/glucagon agonist study
Mar 17, 2025 10:10am
Harbour launches obesity biotech on mission to preserve muscle
Mar 12, 2025 8:15am
Amgen’s late-stage obesity trials expected to read out in ‘27
Mar 5, 2025 1:58pm
BioMed X, Barbados government team up in unique research collab
Feb 20, 2025 10:45am
Aardvark secures $94M IPO to fund appetite-suppressant trials
Feb 13, 2025 8:10am
